Moderna « Search Results « Science and Enterprise

Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

By Alan, on March 23rd, 2023%

Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

Moderna to Build mRNA Vaccine Plant in Canada

By Alan, on August 10th, 2021%

The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada

Moderna Expands Vaccine Research, Mfring in Asia

By Alan, on May 24th, 2021%

Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia

Moderna Supplying 500M Vaccine Doses to Covax

By Alan, on May 3rd, 2021%

Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries. . . . → Read More: Moderna Supplying 500M Vaccine Doses to Covax

Moderna Developing Flu, HIV, Nipah Vaccines

By Alan, on January 11th, 2021%

Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases. . . . → Read More: Moderna Developing Flu, HIV, Nipah Vaccines

Moderna Gains $483M for Covid-19 Vaccine

By Alan, on April 17th, 2020%

A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials. . . . → Read More: Moderna Gains $483M for Covid-19 Vaccine

Moderna Funding University Immunology Research

By Alan, on September 27th, 2019%

A biotechnology enterprise is financing a collaboration with Harvard Medical School that aims to discover new mechanisms for treating immune system disorders. . . . → Read More: Moderna Funding University Immunology Research

Moderna, Merck Partner on Personal Cancer Vaccines

By Alan, on June 29th, 2016%

Scanning electron micrograph of a human T-cell lymphocyte (National Institute of Allergy and Infectious Diseases, NIH)

29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of . . . → Read More: Moderna, Merck Partner on Personal Cancer Vaccines

A Good Run

By Alan, on December 11th, 2023%

After 13 and a half years, the intersection of science and business remains a compelling subject, but there are other things I now want to do, and it’s time to bring Science & Enterprise to a close. . . . → Read More: A Good Run

Trial Set to Test Inhaled mRNA for Viral Infections

By Alan, on November 28th, 2023%

A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions. . . . → Read More: Trial Set to Test Inhaled mRNA for Viral Infections

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise